Videos de Experimentos Relacionados
La muerte súbita inexplicable de muerte súbita.
Lancet (London, England)
|January 11, 1997
Resumen
No abstract available in PubMed .
Videos de Conceptos Relacionados
También podría leer
Artículos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Ordenar por
Same author
Tocilizumab provides a potential therapeutic option for the management of hyperhaemolysis syndrome in sickle cell disease: A case series and brief narrative overview of the literature.
Transfusion medicine (Oxford, England)·2025
Same author
Clinical challenges and proposed solutions for patients with invasive lobular breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author
Multiple mediation analysis of a task-shared psychosocial intervention for perinatal anxiety: Exploratory findings from a randomized controlled trial in Pakistan.
Journal of affective disorders·2024
Same author
Feasibility and acceptability of a culinary nutrition programme for adults with mild-to-moderate intellectual disability: FLIP Food and Lifestyle Information Programme.
Journal of applied research in intellectual disabilities : JARID·2024
Same author
Right ventricular assessment of the adolescent footballer's heart.
Echo research and practice·2024
Same author
Prevalence and clinical significance of electrocardiographic complete right bundle branch block in young individuals.
European journal of preventive cardiology·2024
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)·2026
Same journal
Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.
Lancet (London, England)·2026
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026